Gene · 7402
NIH grants2,352
NIH grants whose papers are about the gene, through NIH's grant-paper links.
81 to 100 of 2,352
Download this page as JSON| Grant | Title | UTRN papers | Newest fiscal year |
|---|---|---|---|
| R50CA211199 | Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center Level | 2 | 2025 |
| T32AR053461 | Training in Muscle Biology and Muscle Disease | 2 | 2025 |
| T32ES007015 | Molecular & Environmental Toxicology Predoctoral Training Program | 2 | 2025 |
| T32HL007828 | Cardiovascular Research Training Program | 2 | 2025 |
| T32HL076124 | Cardiovascular Bioengineering Training Program | 2 | 2025 |
| T32HL134616 | Training to provide the knowledge, skills, and culture to the next generation of cardiovascular scientists | 2 | 2025 |
| U19AG023122 | Longevity Consortium | 2 | 2025 |
| U24AG021886 | National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD) | 2 | 2025 |
| U24CA076518 | A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research | 2 | 2025 |
| U24HL138660 | Blood and Marrow Transplant Clinical Trials Network DCC- The Medical College of Wisconsin, Inc. | 2 | 2025 |
| U24HL157560 | 1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia | 2 | 2025 |
| U54AI170792 | HARC: HIV accessory and regulatory complexes | 2 | 2025 |
| U54GM104940 | Louisiana Clinical and Translational Science Center | 2 | 2025 |
| ZIAAG007270 | ALZHEIMERS RESEARCH PROJECT: Genetic Markers of Brain Aging | 2 | 2025 |
| ZIABC010788 | Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma | 2 | 2025 |
| ZIANS002946 | Axonal transport of endolysosomal organelles and presynaptic cargos for the maintenance of axon cellular homeostasis and presynaptic function | 2 | 2025 |
| ZIANS003029 | Mitochondrial transport and energy metabolism in synaptic transmission and neuronal degeneration and regeneration | 2 | 2025 |
| F31AI181256 | Characterizing a novel Plasmodium cytoskeletal protein | 1 | 2025 |
| I01BX000163 | Leveraging mitochondrial function to combat radiation therapy-induced microvascular disease | 1 | 2025 |
| I01BX001232 | Cu importer CTR1 Cys189 oxidation in atherosclerosis | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7402/grants?page=5